• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞、神经胶质细胞和神经元在多发性硬化症白质和灰质病变中的作用。

The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

作者信息

Mallucci Giulia, Peruzzotti-Jametti Luca, Bernstock Joshua D, Pluchino Stefano

机构信息

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, Wellcome Trust-MRC Stem Cell Institute and NIHR Biomedical Research Centre, University of Cambridge, CB2 0PY, UK.

Department of Brain and Behavioural Sciences, National Neurological Institute C. Mondino, University of Pavia, 27100 Pavia, Italy.

出版信息

Prog Neurobiol. 2015 Apr;127-128:1-22. doi: 10.1016/j.pneurobio.2015.02.003. Epub 2015 Mar 21.

DOI:10.1016/j.pneurobio.2015.02.003
PMID:25802011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4578232/
Abstract

Multiple sclerosis is one of the most common causes of chronic neurological disability beginning in early to middle adult life. Multiple sclerosis is idiopathic in nature, yet increasing correlative evidence supports a strong association between one's genetic predisposition, the environment and the immune system. Symptoms of multiple sclerosis have primarily been shown to result from a disruption in the integrity of myelinated tracts within the white matter of the central nervous system. However, recent research has also highlighted the hitherto underappreciated involvement of gray matter in multiple sclerosis disease pathophysiology, which may be especially relevant when considering the accumulation of irreversible damage and progressive disability. This review aims at providing a comprehensive overview of the interplay between inflammation, glial/neuronal damage and regeneration throughout the course of multiple sclerosis via the analysis of both white and gray matter lesional pathology. Further, we describe the common pathological mechanisms underlying both relapsing and progressive forms of multiple sclerosis, and analyze how current (as well as future) treatments may interact and/or interfere with its pathology. Understanding the putative mechanisms that drive disease pathogenesis will be key in helping to develop effective therapeutic strategies to prevent, mitigate, and treat the diverse morbidities associated with multiple sclerosis.

摘要

多发性硬化症是成年早期至中年期开始的慢性神经功能障碍的最常见病因之一。多发性硬化症本质上是特发性的,但越来越多的相关证据支持个体的遗传易感性、环境和免疫系统之间存在密切关联。多发性硬化症的症状主要表现为中枢神经系统白质内有髓神经纤维束完整性的破坏。然而,最近的研究也强调了灰质在多发性硬化症疾病病理生理学中迄今未得到充分重视的作用,在考虑不可逆损伤的积累和进行性残疾时,这可能尤为重要。本综述旨在通过分析白质和灰质病变病理学,全面概述多发性硬化症病程中炎症、胶质/神经元损伤和再生之间的相互作用。此外,我们描述了复发型和进展型多发性硬化症共同的病理机制,并分析了当前(以及未来)的治疗方法可能如何与其病理相互作用和/或干扰其病理过程。了解驱动疾病发病机制的假定机制对于制定有效的治疗策略以预防、减轻和治疗与多发性硬化症相关的各种疾病至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c5/4578232/64b56cbcb1fa/emss-65133-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c5/4578232/f7c6050639e4/emss-65133-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c5/4578232/64b56cbcb1fa/emss-65133-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c5/4578232/f7c6050639e4/emss-65133-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c5/4578232/64b56cbcb1fa/emss-65133-f0002.jpg

相似文献

1
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.免疫细胞、神经胶质细胞和神经元在多发性硬化症白质和灰质病变中的作用。
Prog Neurobiol. 2015 Apr;127-128:1-22. doi: 10.1016/j.pneurobio.2015.02.003. Epub 2015 Mar 21.
2
Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.免疫抑制分子CD200和CD200R在正常中枢神经系统和多发性硬化病变中的分布提示神经元-胶质细胞和胶质细胞-胶质细胞之间的相互作用。
J Neuropathol Exp Neurol. 2009 Feb;68(2):159-67. doi: 10.1097/NEN.0b013e3181964113.
3
The Leukocentric Theory of Neurological Disorder: A Manifesto.白细胞中心论与神经紊乱:宣言
Neurochem Res. 2017 Sep;42(9):2666-2672. doi: 10.1007/s11064-017-2279-8. Epub 2017 Apr 25.
4
Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis.小胶质细胞在多发性硬化症脑灰质病变中的多方面作用。
Stem Cells. 2021 Aug;39(8):993-1007. doi: 10.1002/stem.3374. Epub 2021 Mar 25.
5
Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.揭示长期多发性硬化症中区域灰质萎缩与相连白质束病理学之间的关系。
Hum Brain Mapp. 2015 May;36(5):1796-807. doi: 10.1002/hbm.22738. Epub 2015 Jan 27.
6
[Cortical gray matter lesions in multiple sclerosis].[多发性硬化症中的皮质灰质病变]
Brain Nerve. 2015 Apr;67(4):497-504. doi: 10.11477/mf.1416200166.
7
The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.胶质神经元代谢合作在调节多发性硬化症和神经病理性疼痛进展中的作用。
Immunotherapy. 2019 Feb;11(2):129-147. doi: 10.2217/imt-2018-0153.
8
Epstein-Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging.爱泼斯坦-巴尔病毒与多发性硬化症中的免疫微环境:来自高维脑组织成像的见解
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2425670122. doi: 10.1073/pnas.2425670122. Epub 2025 Mar 10.
9
Astrocytes lure CXCR2-expressing CD4 T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis.星形胶质细胞通过 TAK1 介导的趋化因子产生,在多发性硬化症小鼠模型中吸引 CXCR2 表达的 CD4 T 细胞进入灰质。
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8). doi: 10.1073/pnas.2017213118.
10
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.灰质脑病变在多发性硬化症和视神经脊髓炎中的意义。
Neuropathology. 2015 Oct;35(5):481-6. doi: 10.1111/neup.12216. Epub 2015 Jun 16.

引用本文的文献

1
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis.细胞焦亡:肠道微生物群与多发性硬化症之间新发现的联系
Drug Des Devel Ther. 2024 Dec 19;18:6145-6164. doi: 10.2147/DDDT.S489454. eCollection 2024.
2
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.胶质细胞作为与多发性硬化症相关的神经炎症机制中的关键调节者。
Int J Mol Sci. 2024 Sep 4;25(17):9588. doi: 10.3390/ijms25179588.
3
The Smoothened agonist SAG Modulates the Male and Female Peripheral Immune Systems Differently in an Immune Model of Central Nervous System Demyelination.激动剂 SAG 可调节中枢神经系统脱髓鞘模型中雄性和雌性外周免疫系统的不同。
Cells. 2024 Apr 13;13(8):676. doi: 10.3390/cells13080676.
4
Inflammasome Molecular Insights in Autoimmune Diseases.自身免疫性疾病中的炎性小体分子见解
Curr Issues Mol Biol. 2024 Apr 18;46(4):3502-3532. doi: 10.3390/cimb46040220.
5
Stress promotes the infiltration of peripheral immune cells to the brain.压力促进外周免疫细胞向大脑浸润。
Brain Behav Immun. 2023 Jul;111:412-423. doi: 10.1016/j.bbi.2023.05.003. Epub 2023 May 9.
6
Wuzi Yanzong Pill relieves CPZ-induced demyelination by improving the microenvironment in the brain.五子衍宗丸通过改善脑内微环境减轻氯氮平诱导的脱髓鞘病变。
Heliyon. 2022 Dec 10;8(12):e12277. doi: 10.1016/j.heliyon.2022.e12277. eCollection 2022 Dec.
7
Emodin attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis.大黄素可减轻实验性自身免疫性脑脊髓炎中的炎症和脱髓鞘。
Neural Regen Res. 2023 Jul;18(7):1535-1541. doi: 10.4103/1673-5374.358612.
8
Brain proteome-wide association study linking-genes in multiple sclerosis pathogenesis.脑蛋白质组全基因组关联研究将多发性硬化症发病机制中的基因联系起来。
Ann Clin Transl Neurol. 2023 Jan;10(1):58-69. doi: 10.1002/acn3.51699. Epub 2022 Dec 7.
9
Impact of Multiple Sclerosis and Its Association with Depression: An Analytical Case-Control Investigation.多发性硬化症的影响及其与抑郁症的关联:一项分析性病例对照研究。
Healthcare (Basel). 2022 Nov 4;10(11):2218. doi: 10.3390/healthcare10112218.
10
Role of RGC-32 in multiple sclerosis and neuroinflammation - few answers and many questions.少答案,多问题:RGC-32 在多发性硬化症和神经炎症中的作用。
Front Immunol. 2022 Sep 12;13:979414. doi: 10.3389/fimmu.2022.979414. eCollection 2022.

本文引用的文献

1
A randomized controlled phase II trial of riluzole in early multiple sclerosis.一项利鲁唑治疗早期多发性硬化症的随机对照 II 期临床试验。
Ann Clin Transl Neurol. 2014 May;1(5):340-7. doi: 10.1002/acn3.60. Epub 2014 Apr 14.
2
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.浸润多发性硬化症脑部的B细胞在引流性颈部淋巴结中成熟。
Sci Transl Med. 2014 Aug 6;6(248):248ra107. doi: 10.1126/scitranslmed.3008879.
3
Early netrin-1 expression impairs central nervous system remyelination.早期 netrin-1 表达可损害中枢神经系统髓鞘再生。
Ann Neurol. 2014 Aug;76(2):252-68. doi: 10.1002/ana.24201. Epub 2014 Jul 15.
4
Defining the clinical course of multiple sclerosis: the 2013 revisions.多发性硬化症临床病程的定义:2013年修订版
Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.
5
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.阿仑单抗治疗多发性硬化症:长期安全性和疗效。
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):208-15. doi: 10.1136/jnnp-2014-307721. Epub 2014 May 21.
6
The role of the immune system in central nervous system plasticity after acute injury.免疫系统在急性损伤后中枢神经系统可塑性中的作用。
Neuroscience. 2014 Dec 26;283:210-221. doi: 10.1016/j.neuroscience.2014.04.036. Epub 2014 Apr 29.
7
Pathologic heterogeneity persists in early active multiple sclerosis lesions.早期活动期多发性硬化病灶中存在病理异质性。
Ann Neurol. 2014 May;75(5):728-38. doi: 10.1002/ana.24163. Epub 2014 May 13.
8
Macrophages and CNS remyelination.巨噬细胞与中枢神经系统的髓鞘修复。
J Neurochem. 2014 Jul;130(2):165-71. doi: 10.1111/jnc.12705. Epub 2014 Mar 26.
9
The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders.糖脂类芯片在神经免疫性疾病自身抗体检测中的应用。
Curr Opin Chem Biol. 2014 Feb;18:78-86. doi: 10.1016/j.cbpa.2014.01.008. Epub 2014 Feb 2.
10
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.口服特立氟胺治疗复发型多发性硬化症(TOWER):一项随机、双盲、安慰剂对照的 3 期临床试验。
Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23.